180 related articles for article (PubMed ID: 16278007)
1. Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology.
Silvestrelli G; Lanari A; Parnetti L; Tomassoni D; Amenta F
Mech Ageing Dev; 2006 Feb; 127(2):148-57. PubMed ID: 16278007
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease.
Verhoeff NP
Expert Rev Neurother; 2005 Mar; 5(2):277-84. PubMed ID: 15853497
[TBL] [Abstract][Full Text] [Related]
3. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk GL
J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
5. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
Pákáski M; Kálmán J
Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Alzheimer's disease].
Bombois S; Lebert F; Vellas B; Pasquier F
Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
[TBL] [Abstract][Full Text] [Related]
7. [New therapeutic options in Alzheimer's disease].
García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
[TBL] [Abstract][Full Text] [Related]
8. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
Tanović A; Alfaro V
Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
[TBL] [Abstract][Full Text] [Related]
9. Isoprenoids and Alzheimer's disease: a complex relationship.
Cole SL; Vassar R
Neurobiol Dis; 2006 May; 22(2):209-22. PubMed ID: 16406223
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Alzheimer's disease].
López OL; Becker JT
Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic approaches to Alzheimer's disease.
Klafki HW; Staufenbiel M; Kornhuber J; Wiltfang J
Brain; 2006 Nov; 129(Pt 11):2840-55. PubMed ID: 17018549
[TBL] [Abstract][Full Text] [Related]
12. Current and future therapy in Alzheimer's disease.
van Marum RJ
Fundam Clin Pharmacol; 2008 Jun; 22(3):265-74. PubMed ID: 18485144
[TBL] [Abstract][Full Text] [Related]
13. [Research progress on Alzheimer's disease: pathogenesis and medical therapy].
Sheng SL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):101-3. PubMed ID: 15171541
[TBL] [Abstract][Full Text] [Related]
14. Pathological correlates of cognitive decline in Alzheimer's disease.
Thind K; Sabbagh MN
Panminerva Med; 2007 Dec; 49(4):191-5. PubMed ID: 18091671
[TBL] [Abstract][Full Text] [Related]
15. Lines of therapeutics research in Alzheimer's disease.
Shvaloff A; Neuman E; Guez D
Psychopharmacol Bull; 1996; 32(3):343-52. PubMed ID: 8961777
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Alzheimer's disease: current and future therapeutic approaches.
Cummings JL
Rev Neurol Dis; 2004; 1(2):60-9. PubMed ID: 16400259
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway.
Masters CL; Beyreuther K
Brain; 2006 Nov; 129(Pt 11):2823-39. PubMed ID: 17012295
[TBL] [Abstract][Full Text] [Related]
19. The role of nicotinic acetylcholine receptors in Alzheimer's disease.
Oddo S; LaFerla FM
J Physiol Paris; 2006; 99(2-3):172-9. PubMed ID: 16448808
[TBL] [Abstract][Full Text] [Related]
20. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development.
Terry AV; Buccafusco JJ
J Pharmacol Exp Ther; 2003 Sep; 306(3):821-7. PubMed ID: 12805474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
